DePuy Synthes Launches its First Active Spine Robotics and Navigation Platform

The twin-use robotics and standalone navigation platform will grow to be a part of the VELYS™ Enabling Applied sciences Portfolio and combine with current J&J MedTech Backbone merchandise

PALM BEACH GARDENS, Fla., Aug. 2, 2024 /PRNewswire/ — Right now, Johnson & Johnson MedTech* introduced that DePuy Synthes, The Orthopaedics Firm of Johnson & Johnson**, is launching a proprietary dual-use robotics and standalone navigation platform developed in collaboration with eCential Robotics. The system, referred to as the VELYS™ Lively Robotic-Assisted System (VELYS™ SPINE), acquired 510(okay) clearance from the U.S. Food and Drug Administration (FDA) and is meant to be used in planning and instrumenting spinal fusion procedures within the cervical, thoracolumbar and sacroiliac spine.

This new spine expertise was designed to assist surgeons sort out their most advanced challenges. The VELYS™ SPINE system is twin use, that means it options each a standalone navigation and an lively robotics platform that may allow surgeon flexibility of their method and plans. Lively robotics permits for surgical steering tailor-made to surgeon choice. The distinctive options and capabilities of lively robotics expertise are set to ascertain a brand new normal in spine surgical care.

“We’re shaping the subsequent frontier of orthopaedic innovation with a relentless give attention to digital developments and excellence within the subject of surgical robotics and navigation. Our dedication extends to enhancing affected person care by means of important strides in spine surgical procedure,” stated Aldo Denti***, Firm Group Chair, DePuy Synthes. “This can be a main step in rising our VELYS™ Portfolio and in our dedication to supporting spine surgeons and their sufferers with superior instruments.”

The VELYS™ SPINE system is designed to handle the uniquely advanced wants of spine surgeons; the system provides a customizable expertise with pathology-specific workflows, aided by capabilities similar to VELYS™ ADAPTIVE TRACKING TECHNOLOGY and VELYS™ Trajectory Help. It is going to be used with the DePuy Synthes core Backbone portfolio of merchandise, together with the TriALTIS™ Backbone System and Navigation Enabled Devices, the SYMPHONY™ Occipito-Cervico-Thoracic (OCT) System, VIPER PRIME™ System and EXPEDIUM VERSE^® Methods.

“Right now’s panorama of enabling applied sciences options first-generation robotics methods that will face challenges in adapting to particular person surgeon wants,” stated Russell Powers^†, Worldwide President, Backbone, DePuy Synthes. “We acknowledge the pressing want for revolutionary options that supply new methods to interact with enabling applied sciences, returning management to surgeon’s fingers. We consider that the distinctive options and capabilities of lively robotics expertise will set a brand new normal in surgical look after spine sufferers all over the place.”

Beginning immediately, the VELYS™ SPINE system might be displayed all through the U.S. within the MedTech Innovation Expertise cell lab, alongside different applied sciences and merchandise at the moment obtainable in DePuy Synthes’ complete Backbone portfolio. The MedTech Innovation Expertise provides hands-on studying alternatives to surgeons, fellows, residents, and different healthcare professionals. Business availability is anticipated within the first half of 2025. Be taught extra in regards to the VELYS™ SPINE system at www.ActiveRoboticAssistance.com.

About Johnson & Johnson MedTech

At Johnson & Johnson MedTech, we unleash numerous healthcare experience, purposeful expertise, and a ardour for individuals to rework the way forward for medical intervention and empower everybody to stay their finest life attainable. For greater than a century, we’ve got pushed breakthrough scientific innovation to handle unmet wants and reimagine well being. In surgical procedure, orthopaedics, imaginative and prescient, and interventional options, we proceed to assist save lives and create a future the place healthcare options are smarter, much less invasive, and extra customized. For extra info, go to https://thenext.jnjmedtech.com/.

About DePuy Synthes

DePuy Synthes, The Orthopaedics Firm of Johnson & Johnson, offers one of the vital complete orthopaedics portfolios on the earth that helps heal and restore motion for the hundreds of thousands of sufferers we serve. DePuy Synthes options, in specialties together with joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgical procedure and sports activities drugs, along with the VELYS™ Digital Surgical procedure portfolio, are designed to advance affected person care whereas delivering scientific and financial worth to healthcare methods worldwide. Constructing on our proud product innovation and legacy of business firsts, we’re reimagining the orthopaedic panorama with new developments in medical applied sciences and digital surgical procedure throughout all the continuum of care to Preserve Folks Shifting immediately and tomorrow. For extra info, go to www.depuysynthes.com.

Cautions Regarding Ahead-Wanting Statements

This press launch accommodates “forward-looking statements” as outlined within the Personal Securities Litigation Reform Act of 1995 concerning the VELYS™ Lively Robotic Help platform. The reader is cautioned to not depend on these forward-looking statements. These statements are based mostly on present expectations of future occasions. If underlying assumptions show inaccurate or recognized or unknown dangers or uncertainties materialize, precise outcomes may fluctuate materially from the expectations and projections of DePuy Synthes, Inc., Medical System Enterprise Providers, Inc. and/or Johnson & Johnson. Dangers and uncertainties embody, however are usually not restricted to: uncertainty of economic success; challenges to patents; competitors, together with technological advances, new merchandise and patents attained by rivals; manufacturing difficulties and delays; product efficacy or security considerations leading to product recollects or regulatory motion; adjustments to relevant legal guidelines and laws, together with international well being care reforms; adjustments in conduct and spending patterns of purchasers of well being care services and products; and developments towards well being care price containment. An additional listing and descriptions of those dangers, uncertainties and different elements may be present in Johnson & Johnson’s Annual Report on Type 10-Ok for the fiscal yr ended December 31, 2023, together with within the sections captioned “Cautionary Be aware Concerning Ahead-Wanting Statements” and “Merchandise 1A. Threat Components,” and in Johnson & Johnson’s subsequent Quarterly Experiences on Type 10-Q and different filings with the Securities and Trade Fee. Copies of those filings can be found on-line at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. None of DePuy Synthes, Inc., Medical System Enterprise Providers, Inc. nor Johnson & Johnson undertakes to replace any forward-looking assertion on account of new info or future occasions or developments.

*DePuy Synthes represents the services and products of DePuy Synthes, Inc. and its associates.

**Comprising the surgical procedure, orthopaedics, imaginative and prescient, and interventional options companies inside Johnson & Johnson’s MedTech section.

***Aldo Denti is an worker of Medical System Enterprise Providers, Inc.

^†Russell Powers is an worker of Medical System Enterprise Providers, Inc.

Essential Info: Prior to make use of, confer with the directions to be used provided with the system(s) for indications, contraindications, unwanted effects, warnings and precautions.

SOURCE DePuy Synthes